| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |